A product of independent beta probabilities dose escalation design for dual‐agent phase I trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A product of independent beta probabilities dose escalation design for dual‐agent phase I trials

Published:2015-01-29 Issue:8 Volume:34 Page:1261-1276
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Mander Adrian P.¹^ORCID,Sweeting Michael J.²^ORCID

Affiliation:

1. MRC Biostatistics Unit Hub for Trials Methodology Research, Institute of Public Health University Forvie Site Cambridge CB2 0SR U.K.

2. Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care University of Cambridge Cambridge CB1 8RN U.K.

Funder

Medical Research Council

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.6434

Reference22 articles.

1. Dose-Finding with Two Agents in Phase I Oncology Trials

2. Bayesian dose finding in oncology for drug combinations by copula regression

3. A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents

4. Two-Dimensional Dose Finding in Discrete Dose Space

5. A Generalized Continual Reassessment Method for Two-Agent Phase I Trials

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design;Statistics in Medicine;2024-07-29

2. Statistical Frameworks for Oncology Dose-Finding Designs with Late-Onset Toxicities: A Review;Statistical Science;2024-05-01

3. Applications of the partial-order continual reassessment method in the early development of treatment combinations;Clinical Trials;2024-03-30

4. DOD-Combo: Bayesian dose finding design in combination trials with meta-analytic-predictive prior;Journal of Biopharmaceutical Statistics;2024-03-11

5. A comparison of model-free phase I dose escalation designs for dual-agent combination therapies;Statistical Methods in Medical Research;2024-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3